The aerial parts of Cephalaria anatolica yielded two previously undescribed hederagenin-type triterpene glycosides, namely cephosides B (1) and C (2), in addition to eleven known natural compounds. The new compounds were identified as 3 (2) by 1D and 2D NMR spectroscopic data, HRESIMS analysis and chemical evidence. The two new triterpenoid saponins and the n-butanol extract were evaluated for their hemolytic activity in human erythrocyte cells and immunomodulatory properties in activated whole blood cells by PMA plus ionomycin. While only n-butanol extract increased IL-1β concentration strongly with a value of 760.52 pg/mL, cephoside C and n-butanol extract augmented a slight IFN-γ secretion with values of 4874.11 and 4750.20 pg/mL, respectively. None of the compounds changed IL-2 levels significantly and showed hemolytic activity.
Introduction
The genus Cephalaria (Caprifoliacea) comprises about 94 species distributed mainly in the Mediterranean Region and the Middle East. In Turkey there are 40 taxa and 24 of them are endemic [1, 2] . Humans have used Cephalaria genus for many purposes such as dyeing material for the wool, an additive in bread, a traditional medicine to cure rheumatism, lung and cardiac diseases and regulate menstruation [3, 4] . This wide range of usages has led to investigations on different Cephalaria species. Many chemical identification studies have been reported that this genus contains triterpenoid saponins, flavonoids, alkaloids, furofuranic lignans and iridoids [5] [6] [7] [8] [9] [10] [11] [12] [13] . According to these literatures, it is also known that these compounds have different activities including antimicrobial, hemolytic, hypolipidemic, immunomodulating and cytotoxic [7-8, 11-12, 14] .
In the light of these literature data, phytochemical and activity studies were carried out on nbutanol extract of Cephalaria anatolica which is an endemic species to Turkey. Herein we reported totally 13 triterpene glycosides, isolated from C. anatolica and two of them are new, named cephosides B-C (1-2). The structures of the new triterpene glycosides were determined as 3-O-β-D-glucopyranosyl- (2) . The known compounds were identified as davisianoside A (3), davisianoside B (4) [15] , elmalienoside A (5), elmalienoside B (6) [8] , macranthoside A (7) [16] , macranthodin A (8), macranthodin B (9) [17] , akebia saponin D (10), dipsacoside B (11) [18] , 3-O-β-D-glucopyranosyl-(1→3)-α-L-rhamnopyranosyl-(1→2)-α-Larabinopyranosyl hederagenin 28-O-β-D-glycopyranosyl ester (12) [19] and aristatoside A (13) [10] . The structures of these compounds were identified by chemical methods including acidic and alkaline hydrolysis, silylation and extensive spectroscopic analysis, along with 1D, 2D NMR and HRESIMS data. The two new triterpenoid saponins and the n-butanol extract were evaluated for their hemolytic activity in human erythrocyte cells and immunomodulatory properties in activated whole blood cells by PMA plus ionomycin.
Materials and Methods

General
Optical rotations of pure compounds were measured at 23 o C using Rudolp Research Analytical Autopol I automatic polarimeter fitted with a sodium lamp with 1 mL cell. IR spectra were obtained on an ATI Mattson Genesis Series Fourier transform infrared spectrophotometer. NMR experiments were performed on Varian AS 400 MHz and Varian ASP 600 MHz instruments in DMSO-d 6 . All chemical shifts were given in ppm units with reference to tetramethylsilane (TMS) as an internal standard and the coupling constant (J) were in Hz. HRESIMS analyses were carried out using a Bruker LC micro-Q-TOF instrument. Medium pressure liquid chromatography (MPLC) was run using a Buchi system (Buchi C-605 pumps, coupled to a UV detector) with Buchi glass column (26/920). Lichroprep RP-18 (25-40 µm; Merck) and silica gel 60 (0.063-0.200 mm; Merck) were used both for open column chromatography (CC) and MPLC applications. Thin-layer chromatography (TLC) was performed on F254 (Merck) and RP-18 F254 (Merck) precoated aluminum sheets. GC-MS analysis was performed by a Shimadzu GC-MS QP 2010 plus instrument with Rtx-CLP2 cat-42302 apolar column (20 m-0.18 mm ID-0.14 µm df). The sugars for GC-MS analysis were purchased from Sigma. A class II laminar flow cabinet (Thermo Scientific, Germany) inverted microscope (Olympus, Japan), a CO 2 incubator, a 96 well spectrophotometer (Thermo Scientific, Germany) and a Nuve centrifuge (Turkey) were used in biological activity tests. 
Alkaline Hydrolysis of the New Compounds
Pure compounds (1-2) (5 mg each) were refluxed with 5% KOH in water at 95 ºC for 5 h [10] . The mixture was neutralized by 5% HCl in water solution, and concentrated under vacuum to dryness. Then this mixture was extracted with n-BuOH:H 2 O (1:1) solvent system. The n-BuOH layers gave prosapogenin 1a-2a. These prosapogenins were analyzed using 1 H NMR and HRESIMS methods and the results were used for the exact decision of the structures. While alkaline hydrolysis of 1 afforded prosapogenin 1a, which is a new compound according to our literature findings, compound 2 gave davisianoside B (4) [15] which was also afforded as a known triterpene glycoside, in this study. 
Acidic Hydrolysis and GC-MS Analysis of the New Compounds
The identification of the monosaccharide units of the glycosides was performed by GC-MS analysis with authentic samples [9] . Each compound (5 mg) was hydrolyzed with 1 N HCl (2 mL) for 6 h at 90 o C. After extraction with CHCl 3 (3 x 5 mL), the aqueous layer was evaporated to dryness and kept under hi-vac for 24 h. Furthermore, the residue of monosaccharides was dissolved in anhydrous pyridine (1 mL), and then 1 mL of HMDS-TMCS (hexamethyldisilazanetrimethylchlorosilane, 3:1) was added, and the mixture was stirred at 70 o C for 1 h. The mixture was concentrated under a N 2 stream and dissolved in n-hexane for GC-MS analyses. Similarly, a mixture containing standard 
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In vitro Bioactivity Assay
Hemolytic Activity Assay
Hemolytic activity of the molecules was measured according to Nalbantsoy et al. (2011) [20] with some modifications. Red blood cells were obtained from healthy human volunteers. Blood was collected with BD Vacutainer TM (NH 143 I. U., Belliver Industrial Estate, Plymouth, UK). An amount of 7 mL of blood was washed three times using a sterile saline solution (0.89%, w/v NaCl, pyrogen free) and then it was centrifuged at 2000/5 g. The final cell suspension was prepared by diluting the pellet to 0.5% using saline solution. A volume of 0.01 mL of the cell suspension was mixed in U button 96-well microplate with 0.05 mL diluents containing 125, 250 and 500 µg/mL concentrations of molecules in saline solutions. QS-21 was used as a control saponin compound. The mixtures were incubated for 30 min at 37 o C and centrifuged at 800/10 g. The free hemoglobin in the supernatants was measured spectrophotometrically at 412 nm. Saline solution and distilled water were used as minimal and maximal hemolytic controls. The hemolytic percent was developed by the saline control, subtracted from all groups. Each experiment was included triplicates at each concentration. The data were expressed as mean ± standard deviation (S.D.) and examined for their statistical significance of difference with Student t-test, ANOVA and the post hoc test (dunnet referring to homogeneity and normality of the absorbance using SPSS 16.0). P-values of less than 0.05, 0.01 and 0.001 were considered to be statistically significant.
Immunomodulatory Assay: Measurement of the Effects on Cytokine Production
Heparinized peripheral human whole blood obtained from healthy volunteers were stimulated with 50 ng PMA (Sigma, St. Lois, MO, U.S.A.) plus 400 ng ionomycin (Sigma, St. Lois, MO, U.S.A.) for IL-2, IFN- and IL-1 and incubated in the presence of test samples or reference compound QS-21 for 48h. The cultured supernatants were collected and the concentration of the cytokines produced by macrophages or lymphocytes was measured using a commercially available enzyme-linked immunosorbent assay (ELISA) (Vienne, Austria). The assays were performed according to the manufacturer's recommendations. The average absorbance readings of the samples were then compared with the concentrations of the standard curve, and the samples concentrations of each cytokine were calculated. The results of IL-2, IFN- and IL-1 were expressed as picograms per milliliter. The minimum detection limits were 9.1 pg/mL, 0.99 pg/mL, and 0.3 pg/mL for IL-2, IFN- and IL-1, respectively. Diluted supernatants were used for all assays and each assay was performed in triplicate. Human whole blood (containing 20 U/mL heparine) was suspended in RPMI-1640 medium supplemented with %10 FBS, 100 U/mL penicillin and 100 mg/mL streptomycin in a 1:10 ratio. PMA (50 ng/mL) and ionomycin (400 ng/mL) were added to the whole blood for stimulation of immune system cells. The samples were dissolved as stock solution in DMSO at concentration of 5 mg/mL and DMSO was used as negative control. An amount of 1 mL of the heparinized blood which was stimulated by PMA (50 ng/mL) and ionomycin (400 ng/mL) was transferred into each well of 24-well plate and incubated at 37°C for 48 in the absence or presence of 3 µg/mL concentrations of samples or QS-21 as the reference compound. The culture supernatants were then mixed with PBS/0.05% thiomersal at 1:2 ratio and were assayed using the specific ELISA method for IL-2, IFN- and IL-1. The experimental protocol was described in a previous report [20] [21] [22] . The protocol was approved by the Human Ethics Committee of Ege University, and all of the procedures used conformed to the declaration of Helsinki. The subjects were informed about the procedures and signed the informed consent forms (approval number: E.215344).
Results and Discussion
Structure Elucidation
Cephoside B (1) Table 1 Table 2 ) and HSQC spectra established the presence of 65 carbon signals, of which 30 were assigned to the aglycone moiety, comprising six methyl, eleven methylene (one oxygenated), five methine (one oxygenated and one double bond), and eight quaternary carbons (one carbonyl) and 35 to a sugar portion made up of six sugar units. The carbon resonances in the 13 C NMR spectrum, for tertiary six methyl carbons at δ C 13.5 (C-24), 16.1 (C-25), 17.1 (C-26), 25.9 (C-27), 33.2 (C-29), 23.8 (C-30), two olefinic carbons at δ C 122.1, 144.0, the oxygen-bearing methine carbon at δ C 79.9 (C-3) and the primary alcoholic carbon at δ C 62.8 suggested that compound 1 possessed hederagenin as an aglycone [23] . Analysis of the 1D and 2D NMR spectral data (including 1 
H
1 H COSY, HSQC, HMBC) allowed for the establishment of the structure of 1. Its HSQC spectrum permitted the assignment of all the protons to their bonding carbons. The downfield shifts of C-3 (79.9) and C-28 (175.7) of the aglycone indicated that compound 1 is a bisdesmosidic glycoside. 2 Hz, Glc III) and 4.43 (d, J = 7.8 Hz, Gal) which were unambiguously correlated by HSQC experiment to the corresponding carbon resonances at δ C 103.7, 100.3, 104.9, 103.6, 94.6, and 101.6 indicated the presence of six sugar moieties, respectively. The coupling constants showed two β-glycosidic linkages for three glucose units and one galactose unit and two α-glycosidic linkages for one rhamnose and one arabinose units. This fact also confirmed by way of acidic hydrolysis and GC-MS analysis. Analysis of the HMBC spectrum then enabled the connectivity of these spin coupling fragments and the other functional groups. The HMBC correlations between H-1 of arabinose at δ H 4.29 and C-3 of aglycone at δ C 79.9 and between H-1 of glucose III at δ H 5.20 and carbonyl carbon at δ C 175.7 indicated that the glycosidic chains were located at C-3 and C-28 of aglycone, respectively. The other HMBC correlations between H-1 of rhamnose at δ H 5.09 and C-2 of arabinose at δ C 74.4, between H-1 of glucose I at δ H 4.37 and C-3 of rhamnose at δ C 82.2, between H-1 of glucose II at δ H 4.24 and C-3 of glucose I at δ C 80.7 and between H-1 of galactose at δ H 4.43 and C-6 of glucose III at δ C 68.5 proved all the linking points between sugar to sugar units. After the alkaline hydrolysis of 1, the 1 H NMR and HRESIMS data of prosapogenin 1a also confirmed the structure. The overall structure of compound 1 was thus determined as Tables 1 and 2 ) with those of compound 1, suggested that compound 2 had the same hederagenin aglycone [23] . 1D and 2D NMR data indicated that compound 2 possessed another rhamnose unit (Rha II) instead of one of the glucose (Glc II) moiety of compound 1. The sugar part of 2 was found to consist of two glucose units, two rhamnose units, one arabinose and one galactose units in a sugar part of the compound. The analyses of IL-1, IFN- and IL-2 cytokine production in stimulated whole blood by activation with PMA plus ionomycin were determined by ELISA. Cytokines are proteins which represent a vital role in the human immune response. The utilities of cytokines are various and contain roles in normal T-cell-mediated immunity, the inflammatory response, autoimmunity, on cancer and allergy treatments [24] . Compared to the PMA plus ionomicin induced whole blood control group (4480.6 pg/mL), the results show that cephoside C and n-butanol extract enhanced considerable IFN- secretion with values of 4874.11 and 4750.20 pg/mL, respectively. Besides that, n-butanol extract of C. anatolica displayed a strong IL-1 secretion with value of 760.52 pg/mL which is closely linked to the innate immune response through inflammasome-driven host resistance with infection (PMA + ionomisin = 680.20 pg/mL). None of the compounds changed IL-2 levels significantly (see Fig. 2 ). The two new triterpenoid saponins (cephosides B-C, 1-2) and the n-butanol extract were also evaluated for their hemolytic activity in human erythrocyte cells. According to the results, they didn't exhibit hemolytic activity considerably.
Hemolytic and Immunomodulatory Activities
